In addition, compared to combination therapy, anti-VEGF monotherapy can reduce the occurrence of ocular hypertension.<h4>Conclusion</h4>This meta-analysis indicates that monotherapy with anti-VEGF drugs is more effective than the other two treatment methods in reducing CMT in patients with retinal vein occlusion. The gene discussed is VEGFA; the disease is ocular hypertension.